Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

eFFECTOR Therapeutics Secures New Series B Funding

eFFECTOR Therapeutics, an early-stage company focused on the discovery and development of small molecule cancer therapeutics in San Diego, has secured its Series B financing up to USD 56 million. The new funding came from Sectoral Asset Management, a new … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , , , | Leave a comment

Top 5 Articles from Liftstream Blog in 2015

These are the 5 articles most viewed this year…so here is a recap for your to dive back in and read what you missed. 5 Reasons Big-Company Execs are Defecting to Biotech The biotechnology sector remains a long-term outperform relative … Continue reading

Posted in General | Tagged , , , , , , , , , | Leave a comment

Raze Therapeutics raises $24m in Series A funding

Authored by James Sheppard The venture capital giant Atlas Ventures announced that it has launched a newly formed biotech called Raze Therapeutics. Raze will be based in the Boston Biotech Cluster. Atlas was not alone in funding the company and … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Bicycle Therapeutics raises $32m for oncology assets

Authored by James Sheppard The Cambridge based biotech Bicycle Therapeutics announced that it raised $32m in venture financing to continue developing the company’s assets in oncology and ophthalmology. The funding round saw some of the industry’s biggest investor names with … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment

AM-Pharma raises 12.2m Euros

Authored by James Sheppard The Dutch biotech company AM-Pharma announced that it had raised 12.2m Euros in a financing round. AM-Pharma is a biopharmaceutical company that focuses on the development of recap (recombinant human Alkaline Phosphate) for inflammatory conditions. The … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Oslo Cancer Cluster: Innovation, Funding and the Future

Authored by Karl Simpson Recently appointed to the role of General Manager of the Oslo Cancer Cluster, Ketil Widerberg has a clear vision and grand plans for the Oslo cluster. In part, this future lies in the significant global interest among … Continue reading

Posted in Executive Appointments, M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

Bellicum Pharma announces $55m in Series C Funding for Cancer Trials

Authored by James Sheppard The Houston based biotechnology firm Bellicum Pharmaceuticals announced that it had raised $55m in Series C funding. The money will be used to expand ongoing clinical trials for the company’s two leading drug candidates in oncology. … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Immatics receives final 22m Euro Tranche of Series D funding

Authored by James Sheppard The German based biotech company immatics has announced it has received its final tranche of series D funding worth 22m Euros ($30m). The Series D funding was supported by existing investors dievini Hopp Biotech holdings, Wellington … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Gene Therapy Start-up AAVLife raises $12m

Authored by James Sheppard The Paris based biotechnology company, AAVLife announced that it had raised $12m in series A funding for its gene therapy assets. The funding round, led by Versant Ventures, will be used to advance a gene-deleting therapy … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

Swedish biotech Oxthera raises $10m for Orphan Drug Development

Authored by James Sheppard The Swedish biopharmaceutical company Oxthera announced that it had raised $10m from new and existing investors. The aim of the fundraising is to continue the clinical development programme for the company’s lead asset in primary hyperoxaluria. … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap